Nuveen Q1 2026 13F Holdings and Activity Report

I. Institutional Overview

Nuveen, as a premier global asset manager and the investment management arm of TIAA, represents one of the most significant pillars of institutional capital in the modern financial landscape. With a reported portfolio market value reaching a staggering $368.08 billion as of the first quarter of 2026, the institution operates at a scale that necessitates a highly sophisticated, multi-layered approach to capital allocation. This massive asset base is distributed across a vast array of 3,176 individual equity holdings, a figure that immediately signals a philosophy rooted in deep diversification and systemic market participation. Unlike boutique hedge funds that might place concentrated bets on a handful of "high-conviction" names, Nuveen’s portfolio structure suggests its role as a "market ballast"—an institution that seeks to capture broad economic growth while utilizing its immense research capabilities to make tactical tilts in specific sectors and individual securities.

This section shows only part of the complete report. View the app for the full analysis, position-level detail, and quarter-over-quarter tracking.

II. Sector Allocation Analysis

Deeply analyzing the Technology allocation, we see that it is nearly triple the weight of the next largest sector. This suggests that Nuveen’s investment committee believes the "valuation premium" often associated with tech is justified by superior earnings growth and structural competitive advantages. However, within this tech dominance, there is evidence of rotation. By looking at the individual holdings, we can see a shift from pure software plays toward hardware and semiconductor giants. This implies an industry-level insight: the institution may believe that as AI matures, the "picks and shovels" (hardware) remain more essential and perhaps more reasonably valued than the "application layer" (software) which faces increasing competition and margin pressure.

This section shows only part of the complete report. View the app for the full analysis, position-level detail, and quarter-over-quarter tracking.

III. Top 10 Holdings Deep Dive

As the undisputed crown jewel of the portfolio, NVIDIA Corporation accounts for a massive 6.62% of Nuveen’s total equity assets. During the first quarter of 2026, Nuveen increased its position by 3.21%, adding over 4.3 million shares. This is a "conviction holding" of the highest order. The motivation here is clear: Nuveen is doubling down on the primary beneficiary of the global AI infrastructure build-out. Despite the stock's likely significant appreciation leading into 2026, the institution continues to find value in NVIDIA’s dominant market share in data center GPUs and its expanding software ecosystem. The fact that the portfolio weight remained relatively stable (dropping a negligible 0.01% despite the share increase) suggests that the addition was a tactical move to maintain its "market weight" or "overweight" status as the total portfolio value fluctuated. Nuveen is signaling that it believes the AI hardware cycle still has significant "legs" and that NVIDIA remains the most efficient vehicle to capture that growth.

This section shows only part of the complete report. View the app for the full analysis, position-level detail, and quarter-over-quarter tracking.

IV. Major Buys/Additions

The most dramatic move this quarter was the massive addition to AstraZeneca. By increasing its position by nearly 2,400%, Nuveen effectively transformed a negligible "tracking position" into a significant $1.3 billion stake. This is a classic "conviction-driven entry." AstraZeneca, a leader in oncology and rare diseases, likely hit a valuation trough or reached a clinical milestone that Nuveen’s healthcare analysts found irresistible. The motivation here is "growth acceleration bet." In an environment where investors are searching for non-cyclical growth, AstraZeneca’s robust pipeline and its expansion into high-margin biopharmaceuticals make it a premier target. This move signals that Nuveen is willing to move aggressively when it identifies a "mispriced" healthcare giant.

This section shows only part of the complete report. View the app for the full analysis, position-level detail, and quarter-over-quarter tracking.

V. Major Sells and Exits

The $1.49 billion reduction in Microsoft is the most significant "cash-out" operation of the quarter. As discussed, this is a "high amount + high weight" move, qualifying it as a strategic retreat. Nuveen’s analysts likely viewed Microsoft’s valuation as having priced in "perfection" regarding its AI integration and cloud growth. By trimming 8.39% of the position, Nuveen is not saying Microsoft is a bad company, but rather that the "risk-reward" profile has shifted. This capital was immediately redeployed into AstraZeneca and Apple, suggesting a "sell A buy B" rotation where "A" is a fully-valued software giant and "B" is a recovering healthcare or consumer tech leader.

This section shows only part of the complete report. View the app for the full analysis, position-level detail, and quarter-over-quarter tracking.

VI. Investment Insights and Risk Warnings

The logic chain can be summarized as follows: 1. Harvest Gains : Sell down "peak-valuation" software and payment leaders (Microsoft, Visa) that have already priced in significant future growth. 2. Reinvest in Infrastructure : Double down on the "physical" winners of the AI era (NVIDIA, Amphenol, Intel) where the demand for hardware remains insatiable. 3. Build a Defensive Moat : Aggressively expand into "high-certainty" sectors like Healthcare (AstraZeneca, JNJ) and Value Retail (Costco) to protect the portfolio against potential macro volatility or a slowdown in consumer spending. 4. Optimize the Tail : Liquidate smaller, speculative positions (Exact Sciences, CyberArk) to focus research and capital on the highest-conviction "core" names.

This section shows only part of the complete report. View the app for the full analysis, position-level detail, and quarter-over-quarter tracking.

Sources and limitations

This report uses public U.S. Securities and Exchange Commission Form 13F disclosures and structured data maintained by 13F Hub. A 13F filing is a quarter-end snapshot of reportable long positions, is normally published with a delay, and does not disclose every short position, cash balance, bond, derivative, or non-U.S. asset.

Narrative content is prepared from the same-period SEC disclosure and 13F Hub structured data, then checked before publication. This material is for research and education, not personalized investment advice.